Insider · CIK 0001733375

Anicetti Vincent R

Reports to the SEC for 1 company · REDWOOD CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001733375

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-07-06	CHRSCoherus Oncology, Inc.A Award	Chief Operating Officer	AAward	+50K sh	—	—	124,790
2021-07-06	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+150K sh	—	—	150,000
2021-04-28	CHRSCoherus Oncology, Inc.A Award	Chief Operating Officer	AAward	+20K sh	—	—	73,402
2021-03-05	CHRSCoherus Oncology, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+20.3K sh	$9.30	+$189K	80,051
2021-03-05	CHRSCoherus Oncology, Inc.S Sale	Chief Operating Officer	SSale	−20.3K sh	$15.46	−$314K	59,739
2021-03-05	CHRSCoherus Oncology, Inc.S Sale	Chief Operating Officer	SSale	−6,337 sh	$15.46	−$98K	53,402
2021-03-05	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−20.3K sh	—	—	4,688
2021-02-17	CHRSCoherus Oncology, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+2,488 sh	$2.50	+$6,221.244	62,227
2021-02-17	CHRSCoherus Oncology, Inc.S Sale	Chief Operating Officer	SSale	−2,488 sh	$17.45	−$43.4K	59,739
2021-02-17	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−2,488 sh	—	—	0
2021-01-19	CHRSCoherus Oncology, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+2,500 sh	$2.50	+$6,251.25	62,239
2021-01-19	CHRSCoherus Oncology, Inc.S Sale	Chief Operating Officer	SSale	−2,500 sh	$17.94	−$44.9K	59,739
2021-01-19	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−2,500 sh	—	—	2,488
2021-01-11	CHRSCoherus Oncology, Inc.A Award	Chief Operating Officer	AAward	+31.3K sh	—	—	59,739
2021-01-11	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+62.5K sh	—	—	62,500
2021-01-10	CHRSCoherus Oncology, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−4,080 sh	$18.18	−$74.2K	28,489
2020-12-17	CHRSCoherus Oncology, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+2,500 sh	$2.50	+$6,251.25	35,069
2020-12-17	CHRSCoherus Oncology, Inc.S Sale	Chief Operating Officer	SSale	−2,500 sh	$17.51	−$43.8K	32,569
2020-12-17	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−2,500 sh	—	—	4,988
2020-12-07	CHRSCoherus Oncology, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+3,000 sh	$12.37	+$37.1K	35,569
2020-12-07	CHRSCoherus Oncology, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+5,791 sh	$12.70	+$73.5K	41,360
2020-12-07	CHRSCoherus Oncology, Inc.S Sale	Chief Operating Officer	SSale	−8,791 sh	$18.42	−$162K	32,569
2020-12-07	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−3,000 sh	—	—	123,000
2020-12-07	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−5,791 sh	—	—	0
2020-12-04	CHRSCoherus Oncology, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+32.3K sh	$16.75	+$541K	64,860
2020-12-04	CHRSCoherus Oncology, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+16.7K sh	$12.70	+$212K	81,569
2020-12-04	CHRSCoherus Oncology, Inc.S Sale	Chief Operating Officer	SSale	−49K sh	$18.85	−$924K	32,569
2020-12-04	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−32.3K sh	—	—	17,709
2020-12-04	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−16.7K sh	—	—	5,791
2020-12-03	CHRSCoherus Oncology, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+36.7K sh	$17.17	+$631K	69,305
2020-12-03	CHRSCoherus Oncology, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+13K sh	$17.73	+$231K	82,325
2020-12-03	CHRSCoherus Oncology, Inc.S Sale	Chief Operating Officer	SSale	−49.8K sh	$18.67	−$929K	32,569
2020-12-03	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−36.7K sh	—	—	0
2020-12-03	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−13K sh	—	—	49,480
2020-11-18	CHRSCoherus Oncology, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+4,283 sh	$12.70	+$54.4K	36,852
2020-11-18	CHRSCoherus Oncology, Inc.S Sale	Chief Operating Officer	SSale	−4,283 sh	$18.00	−$77.1K	32,569
2020-11-18	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−4,283 sh	—	—	22,500
2020-11-17	CHRSCoherus Oncology, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+2,500 sh	$2.50	+$6,251.25	51,056
2020-11-17	CHRSCoherus Oncology, Inc.S Sale	Chief Operating Officer	SSale	−2,500 sh	$17.50	−$43.7K	48,556
2020-11-17	CHRSCoherus Oncology, Inc.S Sale	Chief Operating Officer	SSale	−12.4K sh	$17.68	−$220K	36,136
2020-11-17	CHRSCoherus Oncology, Inc.S Sale	Chief Operating Officer	SSale	−3,567 sh	$17.68	−$63.1K	32,569
2020-11-17	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−2,500 sh	—	—	7,488
2020-10-19	CHRSCoherus Oncology, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+2,500 sh	$2.50	+$6,251.25	51,056
2020-10-19	CHRSCoherus Oncology, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+717 sh	$12.70	+$9,105.9	51,773
2020-10-19	CHRSCoherus Oncology, Inc.S Sale	Chief Operating Officer	SSale	−3,217 sh	$17.89	−$57.6K	48,556
2020-10-19	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−2,500 sh	—	—	9,988
2020-10-19	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−717 sh	—	—	26,783
2020-09-17	CHRSCoherus Oncology, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+2,500 sh	$2.50	+$6,251.25	51,056
2020-09-17	CHRSCoherus Oncology, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+2,500 sh	$12.70	+$31.8K	53,556
2020-09-17	CHRSCoherus Oncology, Inc.S Sale	Chief Operating Officer	SSale	−5,000 sh	$18.84	−$94.2K	48,556

Recent filings

Accepted (ET)
Jul 84
Anicetti Vincent R0001567619-21-013149
SEC(opens sec.gov)
Apr 304
Anicetti Vincent R0001567619-21-008805
SEC(opens sec.gov)
Mar 94
Anicetti Vincent R0001567619-21-005917
SEC(opens sec.gov)
Feb 194
Anicetti Vincent R0001567619-21-004508
SEC(opens sec.gov)
Jan 214
Anicetti Vincent R0001567619-21-001335
SEC(opens sec.gov)
Jan 134
Anicetti Vincent R0001567619-21-000981
SEC(opens sec.gov)
Jan 124
Anicetti Vincent R0001567619-21-000921
SEC(opens sec.gov)
Dec 214
Anicetti Vincent R0001567619-20-021405
SEC(opens sec.gov)
Dec 94
Anicetti Vincent R0001567619-20-020818
SEC(opens sec.gov)

Companies

Coherus Oncology, Inc.Chief Operating OfficerCHRS

Address

COHERUS BIOSCIENCES, INC. 333 TWIN DOLPHIN DRIVE, SUITE 600

REDWOOD CITY, CA, 94065